← back to search

Xueying Qiao

Hebei Medical University · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Esophageal Cancer Research and Treatment, Lung Cancer Diagnosis and Treatment, Gastric Cancer Management and Outcomes, and Lymphoma Diagnosis and Treatment.
h-index
14
citations
940
works
111
NIH funding
primary concept
email

Recent publications

Development of a prognostic nomogram and risk stratification system for elderly patients with esophageal squamous cell carcinoma undergoing definitive radiotherapy: a multicenter retrospective analysis (3JECROG R-03 A)
BMC Cancer 2025cited by 3position: middledoi
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group Database
International Journal of Radiation Oncology*Biology*Physics 2025cited by 1position: middledoi
Corrigendum to “Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma”. [Europ J Surg Oncol 51 (2025) 109546]
European Journal of Surgical Oncology 2025cited by 0position: middledoi
The impact of radiation-related lymphocyte recovery on the prognosis of locally advanced esophageal squamous cell carcinoma patients: a retrospective analysis
Radiation Oncology 2025cited by 0position: middledoi
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
Therapeutic Advances in Medical Oncology 2024cited by 2position: middledoi
Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma
European Journal of Surgical Oncology 2024cited by 1position: middledoi
Elective nodal irradiation versus involved-field irradiation for stage II–IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes
Radiation Oncology 2023cited by 9position: lastdoi
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database
Haematologica 2023cited by 9position: middledoi
Mucosa-associated lymphoid tissue lymphoma of the trachea treated with radiotherapy: A case report
World Journal of Clinical Cases 2023cited by 3position: middledoi
Tracheoesophageal fistula closure after staged dose-escalated radiotherapy for esophageal squamous cell carcinoma: a case report
Journal of International Medical Research 2023cited by 1position: middledoi
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
Annals of Hematology 2023cited by 1position: middledoi
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T‐cell lymphoma
Cancer Reports 2023cited by 1position: middledoi
Elective Nodal Irradiation vs. Involved-Field Irradiation for Stage Ⅱ-Ⅳ Cervical Esophageal Squamous Cell Carcinoma Patients Undergoing Definitive Concurrent Chemoradiotherapy: A Retrospective Propensity Study with Eight-Year Survival Outcomes
International Journal of Radiation Oncology*Biology*Physics 2023cited by 0position: middledoi
Primary Epithelial-Myoepithelial Carcinoma of the Lung Presenting as Multiple Synchronous Lesions
The Annals of Thoracic Surgery 2022cited by 6position: middledoi
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis
Therapeutic Advances in Medical Oncology 2022cited by 5position: middledoi
Treatment and outcome of a patient with pleural unilocular cystic mesothelial proliferation
Respirology Case Reports 2022cited by 2position: middledoi
Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database
eJHaem 2022cited by 2position: middledoi
Evidence of Cure for Extranodal Nasal-Type NK/T-Cell Lymphoma with Modern Treatment: An Analysis of the CLCG Database
SSRN Electronic Journal 2022cited by 0position: middledoi
Elective nodal irradiation versus involved-field irradiation for stage Ⅱ-Ⅳ cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with eight-year survival outcomes
Research Square 2022cited by 0position: lastdoi
Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
Frontiers in Oncology 2021cited by 32position: middledoi
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey
Acta Oncologica 2021cited by 30position: middledoi
Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study
ESMO Open 2021cited by 25position: middledoi
Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction
Frontiers in Oncology 2021cited by 12position: middledoi
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China
Radiation Oncology 2021cited by 11position: middledoi
Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis
BMC Surgery 2021cited by 10position: lastdoi
Prophylactic cranial irradiation confers favourable prognosis for patients with limited‐stage small cell lung cancer in the era of MRI: A propensity score‐matched analysis
Journal of Medical Imaging and Radiation Oncology 2021cited by 10position: lastdoi
Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A)
Translational Cancer Research 2021cited by 4position: middledoi
The promising outcome with simultaneous integrated boost intensity modulated radiotherapy in confined nasal extranodal NK/T-cell lymphoma
Leukemia & lymphoma/Leukemia and lymphoma 2021cited by 2position: middledoi
[Clinical features and treatment outcome of extranodal nasal-type NK/T-cell lymphoma of the extra-upper aerodigestive tract].
PubMed 2021cited by 1position: middledoi
[The effects of sequence of radiotherapy and chemotherapy on prognosis of patients with early-stage extranodal NK/T cell lymphoma (nasal type) and its individualized application].
PubMed 2021cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jing Li · First People's Hospital of Foshan12 papers (2016–2022)Chanjun Zhen · Hebei Medical University10 papers (2012–2025)Yuxiang Wang · Hebei Medical University9 papers (2015–2018)Wenwen Bai · Hebei Medical University9 papers (2015–2025)Qi Zhan · Tongji University8 papers (2015–2019)Zhiguo Zhou · Hebei Medical University7 papers (2012–2025)Gaofeng Li · Binzhou University7 papers (2019–2025) · 7 papers (2018–2025)Qingsong Pang · Tianjin Medical University Cancer Institute and Hospital6 papers (2019–2025)Chun Han · Hebei Medical University6 papers (2019–2025) · 6 papers (2019–2025)Ming He · Shanghai Jiao Tong University6 papers (2015–2018)Junqiang Chen · Shandong University6 papers (2019–2025)J. Li · Hebei Medical University5 papers (2012–2019)Yuzhi Song · Hebei Medical University5 papers (2012–2021)Xin Wang · China University of Mining and Technology5 papers (2019–2021)Xinchen Sun · Nantong University5 papers (2019–2021)Qiong Yang · Guizhou Education University5 papers (2015–2018)Kaixian Zhang · Xuzhou Medical College5 papers (2019–2021)Jianzhong Cao · Shanxi Medical University4 papers (2020–2023)